BioLineRx BLRX
NASDAQ BLRX
$2.21 +0.23 (+12.40%)
As of: Oct 20, 2026 · 2:30 PM EDT

BioLineRx (BLRX) Current Leases (2020 - 2026)

Updated

BioLineRx's Current Leases was $280,000 in the quarter ended Jun 30, 2026, down 31.4% from $408,000 a year earlier but up 10.7% from the prior quarter.

Analysis

BioLineRx (BLRX) Current Leases (2020 - 2026) Analysis & Trends

As of Dec 31, 2025, Current Leases at BioLineRx came in at $234,000, down 55.2% from the prior year.

  • Current Leases shows a five-year compound annual growth rate of 4.1% (years ended Dec 2020 to Dec 2025).
  • In earlier years, Current Leases was $522,000 in the year ended Dec 31, 2024 (-1.1%), $528,000 in the year ended Dec 31, 2023 (+23.7%), $427,000 in the year ended Dec 31, 2022 (+154.2%) and $168,000 in the year ended Dec 31, 2021 (-12.0%).
  • Quarterly Current Leases has moved between $149,000 (the quarter ended Jun 30, 2022) and $1.68 million (the quarter ended Sep 30, 2021) over five years.
  • Compared with a year earlier, Current Leases has declined for eight straight quarters, with an average decline of 24.8% over the last eight quarters.
  • The best year-over-year quarter for Current Leases over five years was the quarter ended Sep 30, 2023 (growth of 248.3%); the worst was the quarter ended Jun 30, 2022 (a decline of 91.2%).
  • Per Business Quant data, BLRX's Current Leases in the three quarters before the quarter ended Jun 30, 2026 was $253,000 (quarter ended Mar 31, 2026), $234,000 (quarter ended Dec 31, 2025) and $297,000 (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn -
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn -
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn -
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn -
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn -
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn -
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -
10 BioLineRx 9.10 Mn -67.42 Mn 235,000.00 280,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 280,000.00
Mar 31, 2026 253,000.00
Dec 31, 2025 234,000.00
Sep 30, 2025 297,000.00
Jun 30, 2025 408,000.00
Mar 31, 2025 440,000.00
Dec 31, 2024 522,000.00
Sep 30, 2024 517,000.00
Jun 30, 2024 500,000.00
Mar 31, 2024 467,000.00
Dec 31, 2023 528,000.00
Sep 30, 2023 526,000.00
Jun 30, 2023 375,000.00
Mar 31, 2023 379,000.00
Dec 31, 2022 427,000.00
Sep 30, 2022 151,000.00
Jun 30, 2022 149,000.00
Dec 31, 2021 168,000.00
Dec 31, 2020 191,000.00
API Access

BioLineRx Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=BLRX&period=max&api_key=YOUR_API_KEY